Amarin reported 155.11M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Aerie Pharmaceuticals AERI:US $ 61.69M 3M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amarin AMRN:US 155.11M 9.4M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
AstraZeneca AZN:LN 11.54B 4.45B
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Epizyme EPZM:US $ 69.34M 1.9M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
GlaxoSmithKline GSK:LN 7.14B 722M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M